The specific Lactobacillus gasseri strain is one of the latest additions to the company’s microbiome portfolio and has eight clinical trials backing its efficacy.
“There are some other biotics that can help reduce your stress or help relieve anxiety or help improve sleep but finding one that can do all three… this is the first one that really can,” said Vaughn DuBow, senior director product portfolio marketing health & wellness at ADM.
The postbiotic advantage
Postbiotics, which are dead organisms, do not have the same challenges when it comes to formulation as probiotics. They do not have issues with light, moisture or heat sensitivities.
Although a postbiotic is inactivated or killed purposefully, it does not mean that it no longer has activity. In fact, postbiotics are effective for multiple applications.
“They can go into gummies, into chocolate, into any food or beverage that you’d like,” DuBow said. “You’re able to take [this] biotic to new heights that they’ve never been before.”
Besides a formulation advantage, the new strain has proved it can offer clinically measurable benefits. In sleep studies, EEGs showed Lactobacillus gasseri helped people not only fall asleep but stay asleep,
“We can actually get an objective measure to say people are falling asleep faster, they’re staying asleep for longer, and they’re waking up fewer times each night,” DuBow said. “These consumers are seeing actual benefits that can be verified on medical instruments, not just a survey.”
